Practical 510(k) vs PMA vs De Novo FDA Pathway Guide
Practical 510(k) vs PMA vs De Novo guidance for choosing an FDA device pathway based on classification, predicates, risk, and evidence needs
Meditrial Editorial Team2026-10-07T08:07:12+00:00October 5th, 2026|Categories: 510(k), Clinical Trial, FDA, Medical Devices, Meditrial, Regulatory, Regulatory Affairs, USA|
Practical 510(k) vs PMA vs De Novo guidance for choosing an FDA device pathway based on classification, predicates, risk, and evidence needs
Meditrial Editorial Team2026-10-01T12:04:43+00:00September 23rd, 2026|Categories: Clinical Trial, Compliance, Europe, European Union, MDCG, Medical Devices, Meditrial, Regulatory, Regulatory Affairs|
Build a defensible clinical evidence strategy under MDR Annex XIV, from the clinical evaluation plan to PMCF and notified body review.
Meditrial Editorial Team2026-09-17T10:24:52+00:00September 15th, 2026|Categories: Clinical Trial, EMA, EUDAMED, Europe, European Union, MDCG, Medical Devices, Meditrial, Regulatory, Regulatory Affairs|
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
Become part of Meditrial! Subscribe to our newsletter.


















Meditrial Europe - VAT CHE-115.033.718 © 2009 - 2026 | All Rights Reserved | Privacy | Terms of Use | Advertising Policy